Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA3327 BTR-1Summary: BTR-1 is an active anticancer agent that induces cell cycle S-phase arrest and affects DNA replication. -
BA3328 OsajinSummary: Osajin is the main bioactive isoflavone present in the fruit. -
BA3329 BT2Summary: BT2 is a BCKDC kinase inhibitor. -
BA3330 AZD-5991Summary: AZD-5991 is a potent and selective inhibitor. -
BA3331 MIK665Summary: MIK665 (S-64315), a myeloid leukemia sequence 1 inhibitor. -
BA3332 BI-3802Summary: BI-3802 is a highly efficient degradation agent capable of inhibiting the Bric-à-brac (BTB) structural domain with values ≤3nM. -
BA3333 AZD4320Summary: AZD4320 is a novel analog of BH-3, a potent dual inhibitor. -
BA3334 BI-3812Summary: BI-3812 is a potent inhibitor. -
BA3335 SonrotoclaxSummary: Sonrotoclax is an orally effective inhibitor. -
BA3336 S55746Summary: S55746 (BCL201) is a potent, orally available, selective inhibitor with values of 1.3 nM and 3.9 nM, respectively.

